Page 6 - Alanh Auerbach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Soligenix (NASDAQ:SNGX – Get Rating) and Puma Biotechnology (NASDAQ:PBYI – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation. Profitability This table compares Soligenix and Puma Biotechnology’s net margins, […]

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone have a history of invasive breast cancer. And ...

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone have a history of invasive breast cancer. And ...

04.05.2023 - Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2023. Unless otherwise stated, all comparisons are for the first quarter of 2023 compared to the first quarter of ...

StockNews.com upgraded shares of Puma Biotechnology (NASDAQ:PBYI – Get Rating) from a hold rating to a buy rating in a report released on Friday. Separately, HC Wainwright reissued a buy rating and issued a $8.00 target price on shares of Puma Biotechnology in a research report on Monday, March 6th. Puma Biotechnology Stock Up 7.7 […]